beta-lactams has been researched along with daptomycin in 55 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (daptomycin) | Trials (daptomycin) | Recent Studies (post-2010) (daptomycin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 2,266 | 75 | 1,407 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.82) | 18.2507 |
| 2000's | 4 (7.27) | 29.6817 |
| 2010's | 30 (54.55) | 24.3611 |
| 2020's | 20 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Bingen, E; Courvalin, P; Duval, J; Lambert-Zechovski, N; Leclercq, R; Su, QH | 1 |
| Georgopapadakou, N | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Khardori, N | 1 |
| May, T | 1 |
| Cattoir, V; Daurel, C | 1 |
| Chapman, AL; Lessing, MP; Sanderson, F; Seaton, RA; Török, ME | 1 |
| Bayer, AS; Bolaris, M; Dhand, A; Nizet, V; Pogliano, J; Sakoulas, G; Wang, G; Yang, SJ | 1 |
| Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
| Chanda, PK; Mehta, S; Paul, A; Plata, KB; Riosa, S; Rosato, AE; Rosato, RR; Singh, C | 1 |
| Amodio-Groton, M; Hoffman-Roberts, HL; Lamp, KC; Moise, PA; Rashid, M; Rastogi, A; Sakoulas, G; Schweitzer, S; Yoon, MJ | 1 |
| Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
| Berti, AD; Nizet, V; Rose, WE; Sakoulas, G; Tewhey, R | 1 |
| Alshabani, K; Bathina, P; Dalle, D; Gudur, UM; Hayakawa, K; Jaydev, F; Kaye, KS; Khatri, J; Lephart, PR; Marchaim, D; Martin, ET; Muppavarapu, KS; Pogue, JM; Rajuri, SD; Rybak, MJ; Sundaragiri, PR | 1 |
| Dhand, A; Sakoulas, G | 1 |
| Harada, S; Hashizume, H; Nomoto, A; Takahashi, Y | 1 |
| Aboutaleb, M; Barber, KE; Raut, A; Rybak, MJ; Sakoulas, G; Smith, JR | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A | 1 |
| Boccia, G; De Caro, F; Esposito, S; Leone, S; Noviello, S | 1 |
| Córdoba, J; Coronado-Álvarez, NM; Parra, D; Parra-Ruiz, J | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
| Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P | 1 |
| Endimiani, A; Furrer, H; Hirzberger, L; Hirzel, C | 1 |
| Fatouraei, M; Fenn, S; Foster, SJ; Haeusser, DP; Kelley, WL; Margolin, W; Martinez, MP; Renzoni, A; Roch, M; Rosato, AE; Rosato, RR; Turner, RD | 1 |
| Edwards, AM; Pader, V | 1 |
| Bal, AM; David, MZ; Garau, J; Gottlieb, T; Gould, IM; Mazzei, T; Scaglione, F; Tattevin, P | 1 |
| Beukers, AG; Davis, R; Espedido, BA; Jensen, SO; Menon, V; Shackel, N; van Hal, SJ | 1 |
| Chang, SC; Chen, PY; Chen, YC; Chuang, YC; Lin, CY; Wang, JT | 1 |
| Becker, K; Idelevich, EA; Kriegeskorte, A; Peters, G; Schleimer, N; von Eiff, C | 1 |
| Davis, SL; Herc, ES; Mercuro, NJ; Zervos, MJ | 1 |
| Foster, TJ | 1 |
| Ardanuy, C; Carratalà, J; Cuervo, G; Domínguez, MA; Grau, I; Grillo, S; Gudiol, C; Guillem Tió, L; Murillo, O; Pallarès, N; Pujol, M; Shaw, E; Tebé, C | 1 |
| Aoki, K; Fujisaki, M; Hamada, M; Ishii, Y; Kajiwara, C; Kato, K; Kimura, S; Murakami, H; Ono, D; Sasaki, M; Sato, A; Sonoda, S; Tateda, K; Tojo, H; Yamaguchi, T | 1 |
| Abdul-Mutakabbir, JC; Alosaimy, S; Bhatia, S; Davis, SL; Jorgensen, SCJ; Lagnf, AM; Mynatt, RP; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Davis, JS; Holland, TL | 1 |
| Gandhi, TN; Malani, PN | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
| Giuliano, C; Jongekrijg, A; Kale-Pradhan, PB; Rybak, MJ | 1 |
| Atalla, E; Mylonakis, E | 1 |
| Kebriaei, R; Nguyen, L; Rice, SA; Rybak, MJ; Sheikh, Z; Singh, NB; Stamper, KC | 1 |
| Deng, C; Hu, Y; Liao, L; Liu, L; Wang, C; Wang, Z; Ye, C | 1 |
| Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
| Wang, JL; Xu, WH; Yi, YH; Yin, WJ | 1 |
| Agnello, S; Coe, K; Day, SR; Reed, E; Smith, JM; Wardlow, LC | 1 |
| Brown, M; Ofori, R; Reinert, JP | 1 |
| Bayer, AS; Lew, C; Mishra, NN; Rose, WE | 1 |
| de Carvalho, CCCR; Rosato, AE; Taglialegna, A | 1 |
| Bayer, AS; Berti, AD; Lew, C; Pellitteri Hahn, M; Proctor, RA; Rose, WE; Rottier, A; Scarlett, C | 1 |
| Boonthaworn, K; Jayachandran, P; Lasek-Nesselquist, E; Ma, Z; Malik, M; Mathur, A; McDonough, KA; Mishra, S; O'Donnell, N; Pata, JD; Sui, H | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Rentsch, KM | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Wang, JT; Yang, JL | 1 |
15 review(s) available for beta-lactams and daptomycin
| Article | Year |
|---|---|
Antibiotics--past, present, and future.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactams; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Drug Therapy; Fluoroquinolones; Glycopeptides; Humans; Macrolides; Oxazolidinones; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Daptomycin; Dosage Forms; Ertapenem; Humans; Infusions, Parenteral; Lipoglycopeptides; Teicoplanin | 2010 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2014 |
Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome | 2015 |
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Staphylococcal Infections; Vancomycin | 2017 |
Combatting resistant enterococcal infections: a pharmacotherapy review.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections | 2018 |
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2019 |
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Vancomycin | 2021 |
Dosing Considerations for Combination Antistaphylococcal β-Lactam and Glyco/lipopeptide Salvage Therapy for Resistant Gram-Positive Infections: A Systematic Review.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Humans; Lipopeptides; Salvage Therapy; Staphylococcal Infections | 2022 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
2 trial(s) available for beta-lactams and daptomycin
| Article | Year |
|---|---|
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
38 other study(ies) available for beta-lactams and daptomycin
| Article | Year |
|---|---|
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Glycopeptides; Peptides; Streptococcus; Time Factors | 1991 |
Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Design; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Marketing; Mice; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2004 |
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 2005 |
[New antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Ertapenem; Humans; Ketolides; Minocycline; Ofloxacin; Tigecycline; Virginiamycin | 2008 |
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cell Membrane; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2011 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Daptomycin; DNA; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Insecta; Larva; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Nafcillin; Oxacillin; Staphylococcal Infections | 2012 |
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Creatine Kinase; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Registries; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2013 |
β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding | 2013 |
Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Female; Gram-Positive Bacterial Infections; Hospital Costs; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Severity of Illness Index; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Natural lipopeptide antibiotic tripropeptin C revitalizes and synergistically potentiates the activity of beta-lactams against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Diphosphates; Drug Antagonism; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Kinetics; Lipopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Methylation; Microbial Sensitivity Tests; Peptides, Cyclic; Prenylation; Staphylococcus aureus | 2015 |
β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: beta-Lactams; Daptomycin; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Microbial Viability; Vancomycin-Resistant Enterococci | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Daptomycin; DNA Mutational Analysis; DNA, Bacterial; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enterococcus faecium; Ertapenem; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Vancomycin Resistance | 2015 |
In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Colistin; Colony Count, Microbial; Daptomycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Limit of Detection; Microbial Sensitivity Tests; Models, Biological; Models, Statistical | 2015 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits | 2016 |
Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; Daptomycin; Drug Synergism; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Time Factors | 2016 |
Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactams; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Oxacillin; Penicillin-Binding Proteins | 2017 |
Daptomycin: new insights into an antibiotic of last resort.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Vancomycin Resistance | 2017 |
Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Mutation | 2018 |
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin-Resistant Enterococci | 2018 |
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Lincosamides; Linezolid; Microbial Sensitivity Tests; Staphylococcus aureus; Trimethoprim | 2018 |
Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.
Topics: Aged; Bacteremia; beta-Lactams; Daptomycin; Female; Humans; Male; Methicillin; Middle Aged; Propensity Score; Retrospective Studies; Staphylococcus aureus | 2019 |
Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2019 |
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Combination Therapy for MRSA Bacteremia: To ß or Not to ß?
Topics: Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2021 |
β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Membrane; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2021 |
Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Daptomycin; Lipoproteins; Membrane Lipids; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin | 2021 |
Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proteomics; Staphylococcal Infections | 2022 |
Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model.
Topics: beta-Lactams; Bioreactors; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Oxacillin | 2022 |
Advances in clinical antibiotic testing.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Monitoring; Glycopeptides; Humans; Linezolid | 2022 |
The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Monobactams; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |